EUVIMEDEUVIMED entdecken
Crossref

Dacarbazine Resistance in Melanoma Is Driven by Cell Cycle Dysregulation Stemming from Altered Cyclin D1, GSK-3β, and p21 Expression

Chinami Ikushima, Kazuki Nakamura, Kazuyuki Furuta, Eriko Iwata, Noriko Yoshikawa

Anticancer Research · 2026-07 · 46 (7) · 3797-3804

DOI: 10.21873/anticanres.18241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.06.2026. Verfasst von Chinami Ikushima und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan. Hauptthemen laut MEDLINE: Dacarbazine, Drug Resistance, Neoplasm, Cyclin D1, Cyclin-Dependent Kinase Inhibitor p21.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DacarbazineDrug Resistance, NeoplasmCyclin D1Cyclin-Dependent Kinase Inhibitor p21MelanomaMelanoma, ExperimentalAnimalsMiceCell Line, TumorCell CycleCell ProliferationGene Expression Regulation, NeoplasticApoptosis Regulatory ProteinsHumansAntineoplastic Agents, Alkylating

Stichwörter der Autor:innen

Dacarbazinecell cycle dysregulationmelanomaresistant

Substanzen

DacarbazineCyclin D1Cyclin-Dependent Kinase Inhibitor p21Apoptosis Regulatory ProteinsAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan.
  • Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan; norikoy@mukogawa-u.ac.jp.

Zitieren

APA

Ikushima, C., Nakamura, K., Furuta, K., Iwata, E., & Yoshikawa, N. (2026). Dacarbazine Resistance in Melanoma Is Driven by Cell Cycle Dysregulation Stemming from Altered Cyclin D1, GSK-3β, and p21 Expression. Anticancer Research, 46(7), 3797-3804. https://doi.org/10.21873/anticanres.18241

Vancouver

Ikushima C, Nakamura K, Furuta K, Iwata E, Yoshikawa N. Dacarbazine Resistance in Melanoma Is Driven by Cell Cycle Dysregulation Stemming from Altered Cyclin D1, GSK-3β, and p21 Expression. Anticancer Research. 2026;46(7):3797-3804. doi:10.21873/anticanres.18241

BibTeX
@article{Ikushima2026,
  author = {Ikushima, Chinami and Nakamura, Kazuki and Furuta, Kazuyuki and Iwata, Eriko and Yoshikawa, Noriko},
  title = {Dacarbazine Resistance in Melanoma Is Driven by Cell Cycle Dysregulation Stemming from Altered Cyclin D1, GSK-3β, and p21 Expression},
  journal = {Anticancer Research},
  year = {2026},
  volume = {46},
  number = {7},
  pages = {3797--3804},
  doi = {10.21873/anticanres.18241}
}
Kostenlos starten →